asa statement on glp 1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Perioperative Management of GLP-1 Receptor

Improving kynurenic acid levels could be an effective neuroprotective strategy in PD, migraine, and neurodegenerative diseases (78)

Gradually tapering the dose can help your body adjust and may reduce the risk of rapid weight regain

Unlike prescription GLP-1 medications, dietary supplements are not required to demonstrate the same level of effectiveness before being marketed

Nutritional Strategies and Personalized Diet in Autism-Choice or Necessity

L., Newton, D

For a review of data regarding animal or cell-free studies, readers can refer to other recent summaries and the rich body of pioneering work which is, of necessity, given limited coverage here